Endocrinology
Samsca® (tolvaptan tablets)
- Aquaretic
- Selective vasopressin V2-receptor antagonist
- Treatment of clinically significant hypervolemic and euvolemic hyponatremia [serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction], including patients with heart failure and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
| Formulation | Package | Strength | Colour / Appearance |
|---|---|---|---|
| Tablets | 10 tablets/ box | 15 mg | Blue, triangular, shallow-convex, debossed with “OTSUKA” and “15” on one side |
*Please refer to the full prescribing information for details